Non-Invasive Imaging Biomarkers to Predict the Hepatopulmonary Shunt Fraction Before Transarterial Radioembolization in Patients with Hepatocellular Carcinoma
Charlie Alexander Hamm,1,2,* Felix Busch,1,3,* Anna Pöhlmann,4 Annabella Shewarega,5 Yubei He,1 Robin Schmidt,1 Han Xu,1 Gero Wieners,1 Bernhard Gebauer,1 Lynn Jeanette Savic1,2 1Department of Radiology, Campus Virchow-Klinikum, Charité – Universitätsmedizin Berlin, Corporate Member...
Main Authors: | Hamm CA, Busch F, Pöhlmann A, Shewarega A, He Y, Schmidt R, Xu H, Wieners G, Gebauer B, Savic LJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/non-invasive-imaging-biomarkers-to-predict-the-hepatopulmonary-shunt-f-peer-reviewed-fulltext-article-JHC |
Similar Items
-
Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
by: Giulio Eugenio Vallati, et al.
Published: (2021-07-01) -
Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
by: Antonio Facciorusso, et al.
Published: (2020-04-01) -
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
by: Luciana Puleo, et al.
Published: (2023-01-01) -
Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series
by: Sim Vermeulen, et al.
Published: (2023-09-01) -
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
by: Kylie E. Zane, et al.
Published: (2021-10-01)